# Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA

> **NCT06009497** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Non Severe Aplastic Anemia

## Interventions

- **DRUG:** Romiplostim
- **DRUG:** Ciclosporin

## Key facts

- **NCT ID:** NCT06009497
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06009497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06009497, "Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06009497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*